Infectious Diseases CME: Top 10 Free Online Courses in Q1 2023

Infectious Disease Advisor
|

MyCME, the leader in free medical education, offers a host of courses across all infectious diseases. Access the entire library of Infectious Diseases CME and CE for Free.

The top infectious disease CME courses available right now on www.myCME.com featuring courses on hepatitis, COVID-19, Ebola, and more.

Infectious Disease CME Course 1 | Infectious Disease Epidemiology

Program Description

This presentation will cover infectious disease epidemiology. Topics include types of immunity, transmission and outbreaks, herd immunity, infection prevention, and epidemiology investigations. Epidemics and nosocomial infections will also be reviewed.

Educational Objectives

Upon completion, participants will be able to:

  • Differentiate between innate vs adaptive immunity
  • Describe different types of transmission
  • Explain the different types of infectious disease epidemiology investigations
  • Describe the role of herd immunity and reproductive number in infection prevention

Intended Audience

Physicians, Nurse Practitioners, Physician Assistants, Pharmacists, Long Term Care Clinicians, Emergency Medicine clinicians and any other specialty where clinicians need to understand infection prevention and control.

Commercial Supporter

Commercial support was not received for this activity.

Max Credits:

  • 1.00 / AMA PRA Category 1 CreditTM
    1.00 / AAPA Category 1 CME Credit
    1.00 / ANCC Contact Hour
    1.00 / CE for Pharmacists

Expires: June 30, 2025

Infectious Disease CME Course 2 | Infection Prevention Program for Behavioral Health Settings in 7 Steps

Program Description

Basic infection prevention and control concepts are lacking in behavioral health facilities, and many do not have trained Infection Preventionists. This training covers basic concepts, including environment of care, to promote a successful infection prevention program in behavioral health settings.

Education Objectives

Upon conclusion, participants should be better able to:

  • Determine the basic components of an Infection Prevention Program in a behavioral health setting
  • Improve compliance with infection prevention practices
  • Engage health care workers, physicians, and leaders
  • Manage time for infection prevention activities
  • Create an Infection Prevention Program

Intended Audience

Physicians, Nurse Practitioners, Physician Assistants, Pharmacists, Long-Term Care Clinicians, Emergency Medicine clinicians, and any other specialty where clinicians need to understand infection prevention and control

Commercial Supporter

Commercial support was not received for this activity.

Max Credits:

  • 1.00 / AMA PRA Category 1 Credit
  • 1.00 / AAPA Category 1 CME Credit
  • 1.00 / ANCC Contact Hour
  • 1.00 / CE for Pharmacists

Expires: June 30, 2025

Infectious Disease CME Course 3 | New Opportunities in the Treatment of COVID-19

Program Description

Current treatments for the outpatient treatment of COVID-19 have garnered much attention in the medical community and the broader media. Many treatments are not supported by available evidence or carry a risk profile that may not warrant their use. Given the difficulty in outpatient administration of IV or subcutaneous monoclonal antibodies, researchers have been working towards the oral treatment of COVID-19. Several candidates are in late-stage clinical trials, with some emerging clinical data. As such, providers require an educational program that broadly encompasses the testing and treatment of COVID-19, so they will be able to properly counsel patients.

Educational Objectives

Upon completion, participants should be able to:

  • Apply understanding of COVID-19 testing methods to patient counseling and treatment choices.
  • Incorporate knowledge of currently authorized/approved and recommended COVID-19 treatments to the outpatient management of patients with COVID-19.
  • Use knowledge of emerging COVID-19 treatments to better counsel and manage affected patients.

Intended Audience

This program is designed to meet the educational needs of clinicians treating patients with COVID-19 infection.

Commercial Supporter

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

Max Credits:

  • 1.50 / AMA PRA Category 1 Credit(s)
  • 1.50 / AAPA Category 1 CME Credits

Expires: September 1, 2023

Infectious Disease CME Course 4 | Living With HIV: Understanding the Patient Experience and Appreciating the Science – Optimizing Treatment in Patients With HIV

Program Description

 This plot-your-own-course activity will focus on evidence/guidelines for ART optimization in treatment-experienced patients with HIV and provides an overview of emerging antiretrovirals (ARVs).

Educational Objectives

Upon completion, participants should be able to:

  • Apply recommended strategies to increase competency in incorporating a comprehensive sexual history and risk assessment into initial and routine patient visits
  • Select ART regimens that minimize drug-drug interactions and toxicities, support adherence, and consider patient and systemic factors including patient preference
  • Summarize new paradigms and approaches to treating and managing HIV, including potential two-drug ARV combinations

Intended Audience

This educational activity has been designed to meet the needs of US-based HIV specialty clinicians and infectious disease physicians involved in managing care for patients who are at risk for or living with HIV.

Commercial Supporter

This activity is supported by an educational grant from Gilead Sciences, Inc.

Max Credits:

  • 0.75 / AMA PRA Category 1 Credit

Expires: June 21, 2023

Program Description

Olfactory dysfunction is associated with significantly increased risk of mortality and has a substantial negative impact on quality of life. This program provides an overview of the management strategies and treatment options for COVID-19–related loss of smell and other postviral forms of olfactory dysfunction.

Educational Objectives

Upon completion, learners will be better able to:

  • Identify the presentation of olfactory loss and dysfunction
  • Discuss the treatment options and management strategies for people with olfactory loss or dysfunction

Intended Audience

Allergists/Immunologists, Infectious Disease Specialists, Internal Medicine, Family Physicians, NPs and PAs

Commercial Supporter

This activity is not commercially supported.

Max Credits:

  • 0.75 / AMA PRA Category 1 Credit
  • 0.75 / ANCC Contact Hour

Expires: July 29, 2024

Infectious Disease CME Course 6 | Pneumococcal Vaccination Simplified: Which Adults Should Get It and When? – Infographic

Program Description

In January 2022, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) updated and simplified guidelines for the administration of pneumococcal vaccination in adults at risk of pneumococcal infection. Dr. Julio Ramirez and Dr. Ruth Carrico of the Norton Infectious Diseases Institute in Louisville, KY, discuss these updated guidelines and the importance of pneumococcal vaccination in at-risk adults.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Discuss the scope, burden, and risks of pneumococcal disease in adults, including special populations such as the elderly and the immunocompromised
  • Describe the different types of available pneumococcal vaccines, including their characteristics and logistics for use
  • Outline the newly updated ACIP recommendations for pneumococcal vaccination in adults

Intended Audience

Infectious Disease Specialists, Internal Medicine, Family Practice, Geriatric Clinicians, NPs, PAs, and Pharmacists

Commercial Supporter

Supported by an educational grant from Pfizer Inc.

Max Credits:

  • 1.00 / AMA PRA Category 1 Credit(s)
  • 1.00 / CE for Pharmacists

Expires: September 15, 2023

Infectious Disease CME Course 7 | Pediatric Influenza Vaccines: Examining Technology, Efficacy, and Outcomes

Program Description

This educational activity is designed to review the differences between egg-based inactivated, cell culture-based inactivated, and live attenuated influenza vaccines in the pediatric population; and the real-world clinical findings regarding the efficacy of pediatric influenza vaccines and how immunization rates can be improved.

Educational Objectives

Upon completion of the educational activity, participants should be able to:

  • Recognize the differences between, and applications for, egg-based inactivated, cell culture–based inactivated, and live attenuated influenza vaccines in the pediatric population.
  • Examine real-world clinical findings regarding the efficacy of pediatric influenza vaccines and how immunization rates can be improved, including strategies to encourage patient adherence and follow-ups.

Intended Audience

The intended audience for this activity is pediatric nurse practitioners, pediatric physician assistants and other health care professionals involved in the management of pediatric patients with influenza.

Commercial Supporter

This activity is supported by an educational grant from Seqirus USA Inc.

Max Credits:

  • 0.75 / AAPA Category 1 CME Credits
  • 0.75 / ANCC Contact Hours
  • 0.75 / AANP Contact Hours

Expires: October 30, 2023

Infectious Disease CME Course 8 | Network Analysis: Making Quantitative Data Qualitative

Program Description

This presentation will cover network analysis. There will be review of nodes, network ties (edges), and isolates. The process will also cover node level and network level measurements. Network process and analysis will be discussed.

Educational Objectives

Upon completion, participants should be able to:

  • Describe the basic characters of a network
  • Identify 2 practical applications of a network analysis
  • Infer properties of a network from a network map

Intended Audience

Physicians, Nurse Practitioners, Physician Assistants, Pharmacists, Long Term Care Clinicians, Emergency Medicine clinicians and any other specialty where clinicians need to understand infection prevention and control.

Commercial Supporter

Commercial support was not received for this activity.

Max Credits:

  • 1.00 / AMA PRA Category 1 CreditTM
  • 1.00 / AAPA Category 1 CME Credit
  • 1.00 / ANCC Contact Hour
  • 1.00 / CE for Pharmacists

Expires: June 30, 2025

Infectious Disease CME Course 9 | Community-Acquired Pneumonia: Organ Dysfunction and Long-Term Sequelae

Program Description

Two fundamental misunderstandings, that CAP is both acute and localized, have led to misconceptions about its prognosis and treatment. It is crucial for clinicians to understand that pneumonia can affect multiple organ systems and have long-term consequences.

Educational Objectives

Upon completion, participants should be better able to:

  • Describe pneumonia pathogenesis
  • Recognize the types of organ dysfunction associated with pneumonia
  • Identify post-acute sequelae of pneumonia

Intended Audience

This activity is intended for Pulmonologists and Primary Care, MDs, NPs and PAs

Commercial Supporter

This activity is not commercially supported.

Max Credits:

  • 0.50 / AMA PRA Category 1 Credit(s)

Expires: June 15, 2023

Infectious Disease CME Course 10 | Herpes Zoster Vaccination: New Guidance, New Opportunities to Improve Vaccination Rates

Program Description

Recent recommendations for vaccination against herpes zoster (HZ) include an indication for patients who have immunocompromising conditions or are treated with immunosuppressive therapies, a group who, despite being at higher overall risk for HZ and its complications, have been previously excluded from the available vaccine indications. The review of risk factors and current disease burden is key to clinician identification of appropriate recipients of the vaccine. HZ vaccination rates have been low since the approval of the first HZ vaccine, but they are most likely further reduced due to the widespread interruption in preventive healthcare due to the COVID-19 pandemic. Developing strategies and protocols for improved vaccination is an evidence-based way that clinicians can act to improve disease burden.

Educational Objectives

Upon completion of the educational activity, participants should be able to:

  • Describe the disease burden of herpes zoster infection and impact on patient quality of life.
  • Discuss the rationale for herpes zoster vaccination in the immunocompromised/immunosuppressed patient and in those of advanced age.
  • Apply the new ACIP recommendations to identify patients who are immunocompromised/immunosuppressed or advanced in age for appropriate herpes zoster vaccination.
  • Design strategies and protocols to improve uptake of herpes zoster vaccination and series completion in all eligible patients.

Intended Audience

This activity is intended to meet the educational needs of healthcare professionals involved in the care of patients requiring herpes zoster vaccination.

Commercial Supporter

This activity is supported by an educational grant from GlaxoSmithKline.

Max Credits:

  • 1.00 / AMA PRA Category 1 CreditTM
  • 1.00 / CE for Pharmacists

Expires: May 2, 2024

These Infectious Disease CME/CE courses, powered by myCME, are specialty-based courses, resources, and news tailored and curated for you. Specialized topics include these and more:

Make sure to take advantage of these accredited free Infectious Disease CE and CME courses for your continuing education.

  • Latest News Your top articles for Tuesday

  • Haymarket Medical NetworkTop Picks

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More